Table 8

ESs for BP and Lipids With the DASH Pattern

BP
ES3.
  • When all food was supplied to adults with BP 120–159/80–95 mm Hg and both body weight and sodium intake were kept stable, the DASH dietary pattern, compared with a typical American diet of the 1990s, lowered BP by 5–6/3 mm Hg.

  • Strength of Evidence: High

Lipids
ES4.
  • When food was supplied to adults with a total cholesterol level <260 mg/dL and LDL-C level <160 mg/dL and body weight was kept stable, the DASH dietary pattern, compared with a typical American diet of the 1990s, lowered LDL-C by 11 mg/dL, lowered HDL-C by 4 mg/dL, and had no effect on triglycerides.

  • Strength of Evidence: High

DASH DIETARY PATTERN SUBPOPULATIONS
Subpopulations and BP
ES5.
  • When all food was supplied to adults with BP 120–159/80–95 mm Hg and body weight was kept stable, the DASH dietary pattern, compared with the typical American diet of the 1990s, lowered BP in women and men, African-American and non–African-American adults, older and younger adults, and hypertensive and nonhypertensive adults.

  • Strength of Evidence: High

Subpopulations and Lipids
ES6.
  • When all food was supplied to adults with a total cholesterol level <260 mg/dL and LDL-C level <160 mg/dL and body weight was kept stable, the DASH dietary pattern, compared with a typical American diet of the 1990s, lowered LDL-C similarly in subgroups: African-American and non–African-American adults and hypertensive and nonhypertensive adults.

  • Strength of Evidence: Low

ES7.
  • When all food was supplied to adults with a total cholesterol level <260 mg/dL and LDL-C level <160 mg/dL and body weight was kept stable, the DASH dietary pattern, compared with a typical American diet of the 1990s, lowered HDL-C similarly in subgroups: African-American and non–African-American adults, hypertensive and nonhypertensive adults, and men and women.

  • Strength of Evidence: Low

BP indicates blood pressure; DASH, Dietary Approaches to Stop Hypertension; ES, evidence statement; HDL-C, high-density lipoprotein cholesterol.